The mechanisms by which boosting MuSK phosphorylation ameliorates pathology in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy are not well understood, as MuSK is neither mutated nor a direct target in these diseases. This evidence concerns the gene MUSK and proximal spinal muscular atrophy.